Risk of serious bacterial infection associated with tumour necrosis factor-alpha inhibitors in children with juvenile idiopathic arthritis
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Risk of serious bacterial infection associated with tumour necrosis factor-alpha inhibitors in children with juvenile idiopathic arthritis
Authors
Keywords
-
Journal
RHEUMATOLOGY
Volume 57, Issue 2, Pages 273-282
Publisher
Oxford University Press (OUP)
Online
2017-02-25
DOI
10.1093/rheumatology/kex049
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Use of Tumor Necrosis Factor-Alpha Inhibitors in Children and Young Adults With Juvenile Idiopathic Arthritis or Rheumatoid Arthritis
- (2016) Wan-Ju Lee et al. PHARMACOTHERAPY
- Long-term safety of etanercept and adalimumab compared to methotrexate in patients with juvenile idiopathic arthritis (JIA)
- (2015) Jens Klotsche et al. ANNALS OF THE RHEUMATIC DISEASES
- Medically Significant Infections Are Increased in Patients With Juvenile Idiopathic Arthritis Treated With Etanercept: Results From the British Society for Paediatric and Adolescent Rheumatology Etanercept Cohort Study
- (2015) Rebecca Davies et al. Arthritis & Rheumatology
- Trends in prescription of biological agents and outcomes of juvenile idiopathic arthritis: results of the Dutch national Arthritis and Biologics in Children Register
- (2014) Marieke H Otten et al. ANNALS OF THE RHEUMATIC DISEASES
- Recent Trends in Medication Usage for the Treatment of Juvenile Idiopathic Arthritis and the Influence of Tumor Necrosis Factor Inhibitors
- (2014) M. L. Mannion et al. JOURNAL OF RHEUMATOLOGY
- Pharmacovigilance in juvenile idiopathic arthritis patients (Pharmachild) treated with biologic agents and/or methotrexate. Consolidated baseline characteristics from Pharmachild and other national registries
- (2014) Joost Swart et al. Pediatric Rheumatology
- Occurrence of adverse events in patients with JIA receiving biologic agents: long-term follow-up in a real-life setting
- (2014) Maarit Tarkiainen et al. RHEUMATOLOGY
- Incidence and Prevalence of Juvenile Idiopathic Arthritis Among Children in a Managed Care Population, 1996-2009
- (2013) L. R. Harrold et al. JOURNAL OF RHEUMATOLOGY
- Rates of hospitalized bacterial infection associated with juvenile idiopathic arthritis and its treatment
- (2012) Timothy Beukelman et al. ARTHRITIS AND RHEUMATISM
- Rheumatoid arthritis and the incidence of influenza and influenza-related complications: a retrospective cohort study
- (2012) William A Blumentals et al. BMC MUSCULOSKELETAL DISORDERS
- Covariate Selection in High-Dimensional Propensity Score Analyses of Treatment Effects in Small Samples
- (2011) Jeremy A. Rassen et al. AMERICAN JOURNAL OF EPIDEMIOLOGY
- TNF-α Antagonist Use and Risk of Hospitalization for Infection in a National Cohort of Veterans With Rheumatoid Arthritis
- (2011) Michael A. Lane et al. MEDICINE
- 2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: Initiation and safety monitoring of therapeutic agents for the treatment of arthritis and systemic features
- (2011) Timothy Beukelman et al. ARTHRITIS CARE & RESEARCH
- Drug-specific risk of non-tuberculosis opportunistic infections in patients receiving anti-TNF therapy reported to the 3-year prospective French RATIO registry
- (2010) D. Salmon-Ceron et al. ANNALS OF THE RHEUMATIC DISEASES
- Primary immunodeficiencies may reveal potential infectious diseases associated with immune-targeting mAb treatments
- (2010) László Maródi et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Observational Studies of Infections in Rheumatoid Arthritis: A Metaanalysis of Tumor Necrosis Factor Antagonists
- (2010) S. BERNATSKY et al. JOURNAL OF RHEUMATOLOGY
- High-dimensional Propensity Score Adjustment in Studies of Treatment Effects Using Health Care Claims Data
- (2009) Sebastian Schneeweiss et al. EPIDEMIOLOGY
- Utilization Trends of Tumor Necrosis Factor Inhibitors Among Patients with Rheumatoid Arthritis in a United States Observational Cohort Study
- (2009) S. J. LEE et al. JOURNAL OF RHEUMATOLOGY
- Safety and efficacy of combination of etanercept and methotrexate compared to treatment with etanercept only in patients with juvenile idiopathic arthritis (JIA): preliminary data from the German JIA Registry
- (2008) G Horneff et al. ANNALS OF THE RHEUMATIC DISEASES
- Safety and efficacy of up to eight years of continuous etanercept therapy in patients with juvenile rheumatoid arthritis
- (2008) Daniel J. Lovell et al. ARTHRITIS AND RHEUMATISM
- Tumor necrosis factor alpha drugs in rheumatoid arthritis: systematic review and metaanalysis of efficacy and safety
- (2008) Alberto Alonso-Ruiz et al. BMC MUSCULOSKELETAL DISORDERS
- Administrative codes combined with medical records based criteria accurately identified bacterial infections among rheumatoid arthritis patients
- (2008) Nivedita M. Patkar et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- Adalimumab with or without Methotrexate in Juvenile Rheumatoid Arthritis
- (2008) Daniel J. Lovell et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now